B Bilgin Global Mod Global Mod 11 Ağu 2022 #1 Glenmark Pharma revenue falls 6.3% at Rs27,773 million for Q1 The company noted that adjusted EBITDA was ₹4,726 million in the quarter ended June 30, 2022 as against ₹5,736 million in the previous corresponding quarter, with margins of 17%
Glenmark Pharma revenue falls 6.3% at Rs27,773 million for Q1 The company noted that adjusted EBITDA was ₹4,726 million in the quarter ended June 30, 2022 as against ₹5,736 million in the previous corresponding quarter, with margins of 17%
